Drug recall · April 5, 2017
Metronidazole Injection recall
Why: Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24
- Lots / codes
Lot #: A060205; A060209, Exp.Jan 2018
- Quantity
- 72072 units
- Company
- Claris Lifesciences Inc, North Brunswick, NJ
- Distribution
- Nationwide
- Initiated
- March 10, 2017 · Voluntary: Firm initiated
- Classified
- March 24, 2017
- Reported
- April 5, 2017
- Ended
- September 18, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metronidazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.